Board of Directors

Dr. Angeline Beltsos is the Chief Executive Physician and Chief Medical Officer of Kindbody. She is double board certified in Obstetrics and Gynecology (OBGYN) and in Reproductive Endocrinology and Infertility, practicing medicine since 1991. Dr. Beltsos completed her residency in OBGYN at Loyola University in 1995 followed by a fellowship in REI at Washington University in St. Louis, Missouri, completed in 1997. Participates in multiple research projects and scientific publications every year. Received numerous awards in teaching and has been honored as Top Doctor from Castle Connelly for several years. Dr. Beltsos speaks both nationally and internationally. A frequent media resource on the topic of infertility. She is the Executive Chairperson for the Midwest Reproductive Symposium International.

Assistant Clinical Professor and Director of the REI Division in the Department of OBGYN residency programs of Wayne State University. She was a Clinical Assistant Professor for the Department of OBGYN at University of Illinois at Chicago. She is committed to giving back by employing, supporting and inspiring students, interns, gap years, residents and fellows. As a mother of 4, 3 by c-section and 1 by surrogacy, Dr. Beltsos appreciates the journey and the reward of wanting to be a parent.

Dr. Amber Cooper is double board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. She is Chief Medical Officer of Genomics and Laboratory Science with Kindbody where she also serves as Medical and IVF Practice Director in the St. Louis region. She is Associate Professor with Wayne State University School of Medicine as well as Adjunct Assistant Professor within the Department of Obstetrics, Gynecology and Women’s Health at St. Louis University.

She received a medical degree from Loyola University Chicago Stritch School of Medicine. She also holds a Master of Science in Clinical Investigation and some additional training in translational research and graduate genetics. Ever since graduating first in her medical school class she has continued to achieve numerous honors, teaching, patient satisfaction, and surgical awards, and has numerous publications.

She has been actively involved in the American Society for Reproductive Medicine and has served on the Board of Directors of the Society of Reproductive Endocrinology and Infertility in the US. She is President on the executive board of the Midwest Reproductive Symposium International. In addition, she sits on many scientific advisory boards and has been the principal investigator of several research studies and trials.

Dr. Jared Robins graduated from Emory University and received his medical degree from the State University of New York at Stony Brook. He completed his Residency in Obstetrics and Gynecology at The Albert Einstein School of Medicine and his Fellowship in Reproductive Endocrinology and Infertility at The University of Cincinnati. Subsequent to fellowship, he developed and ran Brown University's Program for Fertility Preservation as well as its In-Vitro Maturation Program. Dr. Robins previously worked at Northwestern to develop the clinical and academic Division of REI before leading the international medical team for the Northwestern health system. Recently, Dr. Jared Robins has joined Vios Fertility Institute in the Chicagoland Offices.

As the Medical and Laboratory Director at Columbia University Fertility Center, Eric Forman, MD, HCLD, oversees the medical practice as well as the IVF embryology and andrology laboratories. Dr. Forman has extensive clinical and laboratory research experience. He has published more than 50 articles in peer-reviewed journals on a wide range of topics in assisted reproductive technology (ART).

He has a special interest in using preimplantation genetic screening (PGS) to optimize IVF and improve selection for elective single embryo transfer (eSET). A randomized controlled trial he led demonstrated, for the first time, that transferring a single chromosomally-normal embryo can achieve the same live birth rates as transferring two untested embryos. After publication of this paper, eSET rates skyrocketed and the American Society for Reproductive Medicine references Dr. Forman’s study in its guideline on the number of embryos to transfer in IVF. He also has an interest in fertility preservation, and a study he led proved that egg freezing using the rapid vitrification technology does not increase the risk of genetic abnormalities in the resulting embryos. This study was cited as a “watershed in ART” by one of the world’s leading experts on cryopreservation.

Kathryn Go earned her doctoral degree in molecular biology from the University of Pennsylvania and has been a laboratory director and practicing embryologist since 1984. Kathryn is currently the interim Director of the IVF Laboratory at the Brigham and Women’s Hospital and a teaching associate at the Harvard Medical School.

Kathryn has been on the faculties of the medical schools of the University of Pennsylvania, Thomas Jefferson Medical University, and the University of Massachusetts, and has also taught at the Medical College of Pennsylvania and the Experimental College of Tufts University. Kathryn has served on the executive council of the Society for Assisted Reproductive Technology, been a consultant to the FDA, chair of several postgraduate courses for the American Society of Reproductive Medicine (ASRM), and has served as chair of the Reproductive Biology Professional group of the ASRM. She is also a past President of the New England Fertility Society (NEFS) and is now proud to be on the Scientific Advisory Board of the MRSi.

Is the Muirhead Chair in Obstetrics and Gynecology at the University of Glasgow. Scott’s additional roles include Scientific Advisor to The Fertility Partnership, northern Europe’s largest assisted conception provider, and Medical Director of Access Fertility. His research covers use of biomarkers to individualize care and epidemiology including e-health records and data linkage.

Dr. Williams is currently the Medical Director at Reproductive Fertility Center in Irvine. He also has a consultant position as Senior Vice President of Clinical Development for Inception Fertility. He was previously a Medical Director at Aspire-Houston Fertility Institute as well as a Clinical Professor of Ob/Gyn at the University of Texas McGovern School of Medicine, Houston. He is board certified both in Obstetrics and Gynecology, as well as Reproductive Endocrinology-Infertility. He is a fellow in the American College of Obstetrics and Gynecology, and is a member of the Society for Reproductive Endocrinology and Infertility, and the American Society of Reproductive Medicine. He has served as chair of the Scientific Advisory Boards for both Vivere Health as well as Prelude Fertility, Inc. (2013-19). He has won numerous teaching awards, including the CREOG National Faculty Award for Excellence in Resident Education in 1997, 1999 and 2009. He has been named as one of the Best Doctors in America, as well as one of Houston’s Top Docs. Dr. Williams has published numerous articles in the field of reproductive endocrinology-infertility. He has also given lectures both nationally as well as internationally in the field of infertility and reproductive medicine.